Valsartan and Hydrochlorothiazide
- Product NDC
- 70934-960
- 11-digit product format
- 709340960
- Labeler code
- 70934
- Product ID
- 70934-960_da6f11ed-5e71-e5ff-e053-2995a90aa673
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Valsartan and Hydrochlorothiazide
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA203145
- Marketing category
- ANDA
- Marketing start
- 2022-03-17
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; VALSARTAN
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-960-30 | 70934096030 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-960-30) | 2022-03-17 | 0000-00-00 | No | No | Current |